Rheinmetall's Long-Range Ambitions and Naval Work Mask a Winter of High-Stakes Decisions

Rheinmetall rebounds 23% in a month despite F126 setback, with record €80.5B backlog and new contracts in naval, medical, and drone systems.

The defense contractor’s pipeline keeps thickening with everything from loitering munitions to frigate refits, yet the share price chart still tells a story of unfinished business. Rheinmetall’s stock closed Tuesday at €1,211.80, roughly 10 percent above its 50-day moving average, and has clawed back 23 percent over the past month. That recovery, however, comes after a sharp August sell-off triggered by the government’s cancellation of the F126 frigate program — a blow that forced management to trim full-year revenue guidance to a range of €13.7 billion. The shares remain 40 percent below their 52-week high of €2,007 and are down 22 percent year-to-date.

A fresh batch of orders, large and small

The order book, meanwhile, keeps growing on multiple fronts. Rheinmetall has landed a Danish contract for its Multi Ammunition Softkill System (MASS), a decoy launcher designed to protect warships from incoming missiles. The deal covers frigates of the Absalon and Iver Huitfeldt classes, plus the Royal Danish Navy’s weapons school, with deliveries slated to begin in the fourth quarter of 2027. The order was already booked in the second quarter of 2026. MASS has become a quiet workhorse for the company — more than 400 launchers are now deployed globally, shielding vessels across 18 navies.

On the Bundeswehr side, a supplementary order for mobile field hospitals — expanding a previous purchase from 149 to 165 units — carries a gross value exceeding €500 million, pushing the total value of these medical facilities past €600 million. Production is due to start in the first quarter of 2027.

These individual contracts may appear modest next to the group’s mega-programs, but they feed a record backlog of €80.5 billion as of the end of the second quarter. Management is targeting a backlog of €100–120 billion by year-end 2026, a goal that looks increasingly plausible given the current order velocity.

Long-range firepower and a Boeing tie-up

Beyond the steady drip of procurement wins, Rheinmetall is pushing technological boundaries. Last Thursday, the company reported a milestone for its in-house developed FV-014 loitering munition: during a customer demonstration, the system launched successfully from a containerized rocket launcher mounted on an HX truck — both stationary and while moving. The system achieved a range of up to 100 kilometers, positioning it as a flexible deep-strike option on the battlefield. The test matters strategically because it extends Rheinmetall’s portfolio beyond traditional land systems like the Boxer and could open new markets in unmanned systems.

That development dovetails with a cooperation agreement with Boeing announced on August 10. Rheinmetall will act as system integrator for integrating the MQ-28 Ghost Bat fighter drone into the Bundeswehr — a step toward so-called “Collaborative Combat Aircraft” capabilities, linking manned and unmanned combat aircraft.

Naval modernization and the F126 shadow

On the maritime front, Rheinmetall is undertaking a comprehensive modernization of the frigate “Bayern” of the F123 class on behalf of the German Navy. The goal is to extend the vessel’s service life to 2035. The project includes a new command and weapon engagement system plus upgraded radar sensors, with a contract value in the mid-hundreds of millions of euros.

The Bayern work offers some counterweight to the F126 cancellation, provided it translates into firm order volumes. The same logic applies to the new munitions and drone projects — all of them potential contributors to the backlog, but none yet locked in at scale.

Institutional interest and a packed investor calendar

JPMorgan Chase & Co. published a voting rights notification under German securities law on Tuesday regarding its stake in Rheinmetall — a sign of sustained institutional interest, independent of the bank’s own analyst rating. Investors will have several opportunities to probe management further: Rheinmetall attends the DZ Bank Expert Day in Bremen on August 26, followed in September by investor conferences at Berenberg in Stockholm, Morgan Stanley and Bernstein in London, and Jefferies in New York. These gatherings should offer a platform to explain the recent technological advances and their commercial potential.

The winter decisions that really matter

The near-term contract flow keeps the operational engine running, but the market’s attention is shifting to bigger calls. On December 9, the Bundestag is scheduled to debate the Arminius Boxer mega-order — a firm order volume of roughly €25 billion, of which Rheinmetall’s share would be about €12.4 billion. Contract signing is expected a few days later, with final negotiations set for the second week of September. A service contract for Boxer fleet maintenance, worth around €2 billion to Rheinmetall, could follow in January 2027.

Across the Atlantic, Rheinmetall signed a memorandum of understanding with Lockheed Martin in July for joint production of ATACMS systems at the Unterluess site. Production ramp-up is planned for 2027, with first revenues expected in 2028. CEO Armin Papperger has tempered expectations of a rapid scale-up, noting that replenishing US inventories cannot be accomplished within two years.

The Danish decoy order and the Bundeswehr field hospital expansion won’t move the needle on the company’s overall valuation by themselves. But they send a signal: new business keeps flowing even as flagship programs stumble. With multi-billion-euro decisions looming this winter, that operational resilience is exactly what investors will be watching.